|Articles|December 11, 2020
- Pharmaceutical Executive-12-01-2020
- Volume 40
- Issue 12
Pharmaceutical Executive, December 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
For Investors, ’Tis the Season to be Gratefulover 5 years ago
A ‘Sign’ of the Times: Digital Contract Transformationover 5 years ago
Opening Digital Doors: Remote Selling During COVID-19over 5 years ago
The C-Suite’s Frontline Workers in Digital Changeover 5 years ago
Guiding Advice for Leaders Through COVID and Beyondover 5 years ago
EU Under Pressure to Make Decisions on Data Sharingover 5 years ago
COVID and AMR: Crisis Reframes Antibiotics Fightover 5 years ago
Here’s to Looking AheadAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
2
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
3
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
4
FDA's Timeline for DTC Prescription Drug Ad Oversight
5